Fore Capital
Latest statistics and disclosures from Fore Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, SLV, GDX, EWZ, Dexcom Inc Note 0.375 5/1, and represent 63.15% of Fore Capital's stock portfolio.
- Added to shares of these 10 stocks: SPY (+$52M), SLV (+$43M), GDX (+$23M), EWZ (+$7.7M), Dexcom Inc Note 0.375 5/1 (+$7.5M), Haemonetics Corp Mass (+$7.1M), SMH (+$6.6M), COPX (+$6.5M), IQV (+$6.2M), TCOM (+$6.0M).
- Started 35 new stock positions in NTR, Alibaba Group 0.500 01-Jun-2031, PROP, AMT, FINV, RRC, XLV, QFIN, AR, INDA.
- Reduced shares in these 10 stocks: HYG (-$65M), Shift4 Payments (-$6.6M), Enphase Energy, , , , Bill Com Hldgs, NU, BHC, TMQ.
- Sold out of its positions in Bill Com Hldgs, CNC, Enphase Energy, HYG, Shift4 Payments, UNH, NU, MMYT.
- Fore Capital was a net buyer of stock by $145M.
- Fore Capital has $311M in assets under management (AUM), dropping by 92.70%.
- Central Index Key (CIK): 0001714672
Tip: Access up to 7 years of quarterly data
Positions held by Fore Capital consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Fore Capital
Fore Capital holds 55 positions in its portfolio as reported in the June 2026 quarterly 13F filing
Past Filings by Fore Capital
SEC 13F filings are viewable for Fore Capital going back to 2017
- Fore Capital 2026 Q2 filed Aug. 10, 2026
- Fore Capital 2026 Q1 filed May 8, 2026
- Fore Capital 2025 Q4 filed Feb. 11, 2026
- Fore Capital 2025 Q3 filed Nov. 13, 2025
- Fore Capital 2025 Q2 filed Aug. 11, 2025
- Fore Capital 2025 Q1 filed May 13, 2025
- Fore Capital 2024 Q4 filed Feb. 10, 2025
- Fore Capital 2024 Q3 filed Nov. 12, 2024
- Fore Capital 2024 Q2 filed Aug. 7, 2024
- Fore Capital 2024 Q1 filed May 7, 2024
- Fore Capital 2023 Q3 filed Nov. 6, 2023
- Fore Capital 2023 Q2 filed Aug. 9, 2023
- Fore Capital 2023 Q1 filed May 9, 2023
- Fore Capital 2022 Q4 filed Feb. 13, 2023
- Fore Capital 2022 Q3 filed Nov. 10, 2022
- Fore Capital 2022 Q2 filed Aug. 8, 2022